STERIS plc

STERIS supplies infection prevention, contamination control, and surgical care products and services worldwide. The company operates through three segments: Healthcare, Applied Sterilization Technologies (AST), and Life Sciences. Healthcare provides infection prevention consumables, surgical tables, automated reprocessing units, washers, sterilizers, endoscopy accessories, and equipment repair and outsourced sterile processing. AST offers contract sterilization modalities, laboratory testing, and automated sterilization machinery and control systems. Life Sciences supplies pharmaceutical detergents, cleanroom disinfectants, sterilizers, vaporized hydrogen peroxide room decontamination systems, and high-purity water generators. Its customer base includes healthcare providers, hospitals, endoscopy and ambulatory surgery centers, and pharmaceutical and medical device manufacturers.

The company operates manufacturing, packaging, laboratory, and contract sterilization facilities across the Americas, Europe, and Asia, and sells products and services globally. STERIS employs an average of approximately 18,000 workers worldwide across its divisions. While the provided text mentions compliance with environmental laws in Ireland and the United States, it does not disclose the specific headquarters location.

Summary of the business section of Steris's latest annual report, written by StockData.

“Actually paid” adjusts reported pay for changes in the value of equity awards. Shareholder return assumes $100 invested at the start of the measurement period, as disclosed by the company.

“As of March 31, 2023, we had over 17,000 employees throughout the world of which less than 12% are represented by work councils or labor unions.”